🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Ken Fisher’s RYTM Holdings & Trades

First Buy
Q3 2026
Duration Held
1 Quarters
Largest Add
Q3 2026
+105,999 Shares
Current Position
105,999 Shares
$10.09 M Value

Ken Fisher's RYTM Position Overview

Ken Fisher (via Fisher Asset Management, LLC) currently holds 105,999 shares of Rhythm Pharmaceuticals, Inc. (RYTM) worth $10.09 M, representing 0.00% of the portfolio. First purchased in 2026-Q3, this recently established position has been held for 1 quarters.

Based on recent 13F filings, Ken Fisher has initiated a new position in RYTM, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.

Analysis based on 13F filings available since 2013 Q2

Ken Fisher's Rhythm Pharmaceuticals (RYTM) Holding Value Over Time

Track share changes against reported price movement

Quarterly Rhythm Pharmaceuticals (RYTM) Trades by Ken Fisher

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q3 2026 +105,999 New Buy 105,999 $95.21

Ken Fisher's Rhythm Pharmaceuticals Investment FAQs

Ken Fisher first purchased Rhythm Pharmaceuticals, Inc. (RYTM) in Q3 2026, acquiring 105,999 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Ken Fisher has held Rhythm Pharmaceuticals, Inc. (RYTM) for 1 quarters since Q3 2026.

Ken Fisher's largest addition to Rhythm Pharmaceuticals, Inc. (RYTM) was in Q3 2026, adding 105,999 shares worth $10.09 M.

According to the latest 13F filing for Q3 2026, Ken Fisher's firm, Fisher Asset Management, LLC, owns 105,999 shares of Rhythm Pharmaceuticals, Inc. (RYTM), valued at approximately $10.09 M.

As of the Q3 2026 filing, Rhythm Pharmaceuticals, Inc. (RYTM) represents approximately 0.00% of Ken Fisher's publicly disclosed stock portfolio, making it one of their key holdings.

Ken Fisher's peak holding in Rhythm Pharmaceuticals, Inc. (RYTM) was 105,999 shares, as reported at the end of Q3 2026.